Pfizer Opens Oncology R&D Center in San Diego

Pfizer opened an oncology research and development center in May of 2026 on the Torrey Heights campus in San Diego. Designed by DGA, the 230,000-sf facility will accelerate the creation of groundbreaking medicines for gastrointestinal, hematologic, thoracic, breast, and genitourinary cancers. Supporting a broad pipeline of innovative biologics, the leading-edge complex features specialized laboratories dedicated to small-molecule drugs, antibody-drug conjugates (ADCs), and multispecific antibodies. 

The purpose-built hub brings together critical capacities to strengthen end-to-end R&D operations and ensure a highly efficient pathway between discovery and patient impact, while maintaining the optimal scientific approach. The state-of-the-art structure will house approximately 650 investigators and staff, driving impactful collaborations across the boundaries of biology, translational research, and early clinical development. DPR Construction served as general contractor in association Project Management Advisors (PMA).

Breakthrough Properties’ Torrey Heights property was designed by Flad Architects to offer 520,000 sf of premier laboratory and office space for life sciences tenants. The 10-acre site accommodates a 400-seat conference venue, a 25,000-sf amenity building, sophisticated fitness environments, and multiple dining options. Delivered by Clark Construction Group, the campus opened in September of 2024 and has achieved LEED Gold certification.